PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9495824-1 1998 To extend our knowledge of the pharmacological profile of human alpha4beta2 neuronal nicotinic receptors, we investigated the action of hexamethonium on the major brain human nicotinic acetylcholine receptor (nAChR) stably expressed in human embryonic kidney 293 cells. Hexamethonium 136-149 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 175-207 22902499-5 2012 KEY FINDINGS: Both nAChR and mAChR antagonists (hexamethonium and methacine, respectively), per se, elevated histamine-releasing activity of the HMC-1 and suppressed the MC responses to most of investigated activators (carbachol, compound 48/80, and to a lesser extent aIgG). Hexamethonium 48-61 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 19-24 20105082-3 2010 Dihydrobetaerythroidine (antagonist of heteromeric nAChR), and hexamethonium (antagonist of peripheral nAChR), fully antagonized the effect of MDMA. Hexamethonium 63-76 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 103-108 23149874-7 2012 Nicotinic acetylcholine receptor (nAChR) blocker hexamethonium, MEK1/2 inhibitor PD98059, p38 MAPK inhibitor SB203580 and NF-kappaB inhibitor PDTC almost completely abolished nicotineinduced CRP expression in mRNA and protein levels in U937 macrophages. Hexamethonium 49-62 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 0-32 23149874-7 2012 Nicotinic acetylcholine receptor (nAChR) blocker hexamethonium, MEK1/2 inhibitor PD98059, p38 MAPK inhibitor SB203580 and NF-kappaB inhibitor PDTC almost completely abolished nicotineinduced CRP expression in mRNA and protein levels in U937 macrophages. Hexamethonium 49-62 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 34-39 17784838-6 2007 Furthermore, the antiapoptotic effect of nicotine was blocked completely by nicotinic acetylcholine receptor (nAChR) antagonist hexamethonium. Hexamethonium 128-141 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 76-108 17784838-6 2007 Furthermore, the antiapoptotic effect of nicotine was blocked completely by nicotinic acetylcholine receptor (nAChR) antagonist hexamethonium. Hexamethonium 128-141 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 110-115 9495824-1 1998 To extend our knowledge of the pharmacological profile of human alpha4beta2 neuronal nicotinic receptors, we investigated the action of hexamethonium on the major brain human nicotinic acetylcholine receptor (nAChR) stably expressed in human embryonic kidney 293 cells. Hexamethonium 136-149 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 209-214 25503516-5 2015 N-acetyl-cysteine (ROS scavenger) or hexamethonium [nicotinic acetylcholine receptor (nAChR) antagonist] attenuated the CSE-induced increase in intracellular ROS, activation of AMPK and NF-kappaB, as well as IL-8 induction, which suggests that nAChRs and ROS are important. Hexamethonium 37-50 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 52-84 25503516-5 2015 N-acetyl-cysteine (ROS scavenger) or hexamethonium [nicotinic acetylcholine receptor (nAChR) antagonist] attenuated the CSE-induced increase in intracellular ROS, activation of AMPK and NF-kappaB, as well as IL-8 induction, which suggests that nAChRs and ROS are important. Hexamethonium 37-50 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 86-91 34273166-11 2021 Using nicotinic acetylcholine receptor (nAChR) blockers alpha-bungarotoxin and hexamethonium bromide we found that the effects of nicotine on intracellular Ca2+ and oxidative stress were mediated by alpha7 and alpha3 nAChR. Hexamethonium 79-100 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 6-38 34273166-11 2021 Using nicotinic acetylcholine receptor (nAChR) blockers alpha-bungarotoxin and hexamethonium bromide we found that the effects of nicotine on intracellular Ca2+ and oxidative stress were mediated by alpha7 and alpha3 nAChR. Hexamethonium 79-100 cholinergic receptor nicotinic alpha 4 subunit Homo sapiens 40-45